Mouse p53-deficient cancer models as platforms for obtaining genomic predictors of human cancer clinical outcomes.
Mutations in the TP53 gene are very common in human cancers, and are associated with poor clinical outcome. Transgenic mouse models lacking the Trp53 gene or that express mutant Trp53 transgenes produce tumours with malignant features in many organs. We previously showed the transcriptome of a p53-d...
Guardado en:
Autores principales: | Marta Dueñas, Mirentxu Santos, Juan F Aranda, Concha Bielza, Ana B Martínez-Cruz, Corina Lorz, Miquel Taron, Eva M Ciruelos, José L Rodríguez-Peralto, Miguel Martín, Pedro Larrañaga, Jubrail Dahabreh, George P Stathopoulos, Rafael Rosell, Jesús M Paramio, Ramón García-Escudero |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/aa4b88e29f75412e9bf812a4c6c27a2d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Targeting codon 158 p53-mutant cancers via the induction of p53 acetylation
por: Li Ren Kong, et al.
Publicado: (2020) -
Novel p53 therapies for head and neck cancer
por: Mario R. Castellanos, et al.
Publicado: (2016) -
Complexes formed by mutant p53 and their roles in breast cancer
por: Bellazzo A, et al.
Publicado: (2018) -
The p53 breast cancer tissue biomarker in Indian women
por: Patil V, et al.
Publicado: (2011) -
p53 Codon 72 Polymorphism and Risk of Cervical Cancer
por: OJEDA,JOSÉ M, et al.
Publicado: (2003)